Literature DB >> 18577440

Therapeutic effect of tripterine on adjuvant arthritis in rats.

Hong Li1, Yun-Yi Zhang, Hui-Wen Tan, Yong-Feng Jia, Duan Li.   

Abstract

AIMS OF THE STUDY: Tripterygium wilfordii Hoog f., a perennial vine, is used in traditional Chinese medicine for treatment of rheumatoid arthritis. This study was to determine whether tripterine, isolated from Tripterygium wilfordii Hoog f., had therapeutic effects on adjuvant arthritis.
MATERIALS AND METHODS: Adjuvant arthritis (AA) was induced in rats on day 0. Tripterine 5, 10 and 20 mg kg(-1)day(-1), or prednisone 10 mg kg(-1)day(-1) was given to rats intragastrically from day 19 to day 24.
RESULTS: Tripterine significantly inhibited paw swelling and bone destruction in AA rats. Serum level of IgG anti-Mycobacterium tuberculosis antibodies and delayed-type hypersensitivity (DTH) induced by Mycobacterium tuberculosis were also decreased by tripterine. The effects of tripterine were associated with decreased interleukin-1beta (IL-1beta) mRNA expression in ankle joint synovial membrane and tumor necrosis factor-alpha (TNF-alpha) mRNA expression in homogenized paws from adjuvant-induced arthritic rats.
CONCLUSIONS: These findings suggested that tripterine had a therapeutic effect on adjuvant arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577440     DOI: 10.1016/j.jep.2008.05.028

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  27 in total

Review 1.  Control of autoimmune inflammation by celastrol, a natural triterpenoid.

Authors:  Shivaprasad H Venkatesha; Steven Dudics; Brian Astry; Kamal D Moudgil
Journal:  Pathog Dis       Date:  2016-07-11       Impact factor: 3.166

2.  Recombinant human endostatin inhibits adjuvant arthritis by down-regulating VEGF expression and suppression of TNF-α, IL-1β production.

Authors:  Wei Hu; Li-Juan Xia; Fei-Hu Chen; Fan-Rong Wu; Jie Tang; Cun-Zhi Chen; Sheng Jiang; Hui-Hui Chen
Journal:  Inflamm Res       Date:  2012-05-19       Impact factor: 4.575

3.  Effective treatment of rat adjuvant-induced arthritis by celastrol.

Authors:  R Cascão; B Vidal; H Raquel; A Neves-Costa; N Figueiredo; V Gupta; J E Fonseca; L F Moita
Journal:  Autoimmun Rev       Date:  2012-03-03       Impact factor: 9.754

4.  Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.

Authors:  Ying Wang; Lu Cao; Li-Min Xu; Fan-Fan Cao; Bin Peng; Xue Zhang; Yu-Fan Shen; Georges Uzan; Deng-Hai Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-15       Impact factor: 4.147

5.  A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases.

Authors:  Andreas R Baudy; Nandita Saxena; Heather Gordish; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Int Immunopharmacol       Date:  2009-07-21       Impact factor: 4.932

6.  Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.

Authors:  Daniel Paris; Nowell J Ganey; Vincent Laporte; Nikunj S Patel; David Beaulieu-Abdelahad; Corbin Bachmeier; Amelia March; Ghania Ait-Ghezala; Michael J Mullan
Journal:  J Neuroinflammation       Date:  2010-03-08       Impact factor: 8.322

7.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.

Authors:  Feng Wu; Min Han; John X Wilson
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

9.  Identification of geranylgeranyl diphosphate synthase genes from Tripterygium wilfordii.

Authors:  Meng Zhang; Ping Su; Yong-Jin Zhou; Xiu-Juan Wang; Yu-Jun Zhao; Yu-Jia Liu; Yu-Ru Tong; Tian-Yuan Hu; Lu-Qi Huang; Wei Gao
Journal:  Plant Cell Rep       Date:  2015-10-08       Impact factor: 4.570

Review 10.  Heat shock protein 90 inhibition and multi-target approach to maximize cardioprotection in ischaemic injury.

Authors:  Shant Der Sarkissian; Henry Aceros; Pierre-Marc Williams; Catherine Scalabrini; Mélanie Borie; Nicolas Noiseux
Journal:  Br J Pharmacol       Date:  2020-05-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.